LL-37 (Human) [4759]
LL-37 (Human)
| SMILES | CCC(C)C(NC(=O)C(CCCCN)NC(=O)C(CCC(=O)O)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CCCCN)NC(=O)C(CCCN=C(N)N)NC(=O)C(Cc1ccccc1)NC(=O)C(Cc1ccccc1)NC(=O)C(CC(=O)O)NC(=O)CNC(=O)C(CC(C)C)NC(=O)C(N)CC(C)C)C(=O)NCC(=O)NC(CCCCN)C(=O)NC(CCC(=O)O)C(=O)NC(Cc1ccccc1)C(=O)NC(CCCCN)C(=O)NC(CCCN=C(N)N)C(=O)NC(C(=O)NC(C(=O)NC(CCC(N)=O)C(=O)NC(CCCN=C(N)N)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(CC(=O)O)C(=O)NC(Cc1ccccc1)C(=O)NC(CC(C)C)C(=O)NC(CCCN=C(N)N)C(=O)NC(CC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(C(=O)N1CCCC1C(=O)NC(CCCN=C(N)N)C(=O)NC(C(=O)NC(CCC(=O)O)C(=O)NC(CO)C(=O)O)C(C)O)C(C)C)C(C)CC)C(C)C)C(C)CC |
| InChIKey | POIUWJQBRNEFGX-UHFFFAOYSA-N |
| Sequence | LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES |
| HELM | PEPTIDE1{L.L.G.D.F.F.R.K.S.K.E.K.I.G.K.E.F.K.R.I.V.Q.R.I.K.D.F.L.R.N.L.V.P.R.T.E.S}$$$$ |
Chemical Properties
| Hydrogen bond acceptors | None |
| Hydrogen bond donors | None |
| Rotatable bonds | None |
| Log P | None |
| Molecular weight (Da) | None |
Database connections
|
|
No bioactivity data available.
LL-37 (Human)
Drug properties
| Molecular type | Peptide |
| Physiological/Surrogate | Surrogate |
| Approved drug | No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0
Database connections
|
|